Michela Ceccolini

1.3k total citations
21 papers, 734 citations indexed

About

Michela Ceccolini is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Michela Ceccolini has authored 21 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Michela Ceccolini's work include Multiple Myeloma Research and Treatments (16 papers), Cancer Treatment and Pharmacology (5 papers) and Bone health and treatments (4 papers). Michela Ceccolini is often cited by papers focused on Multiple Myeloma Research and Treatments (16 papers), Cancer Treatment and Pharmacology (5 papers) and Bone health and treatments (4 papers). Michela Ceccolini collaborates with scholars based in Italy and United States. Michela Ceccolini's co-authors include Michèle Cavo, Elena Zamagni, Michele Baccarani, Patrizia Tosi, Giulia Perrone, Paola Tacchetti, Delia Cangini, S Tura, Claudia Cellini and Annamaria Brioli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancers.

In The Last Decade

Michela Ceccolini

18 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michela Ceccolini Italy	11	625	441	387	75	47	21	734
Nicola Lang Germany	7	369 0.6×	296 0.7×	266 0.7×	63 0.8×	45 1.0×	10	578
Silvia Buttignol Italy	5	657 1.1×	392 0.9×	301 0.8×	107 1.4×	82 1.7×	8	716
Christiane Heiß Germany	11	614 1.0×	292 0.7×	403 1.0×	158 2.1×	142 3.0×	17	784
Diane Weber United States	7	339 0.5×	198 0.4×	202 0.5×	42 0.6×	26 0.6×	13	457
Francesca Carobolante Italy	6	406 0.6×	274 0.6×	215 0.6×	64 0.9×	40 0.9×	7	496
Terri L. Alpe United States	3	328 0.5×	227 0.5×	187 0.5×	49 0.7×	45 1.0×	6	381
M Masi Italy	13	458 0.7×	129 0.3×	218 0.6×	105 1.4×	27 0.6×	26	597
José J. Pérez Spain	12	593 0.9×	167 0.4×	317 0.8×	201 2.7×	25 0.5×	27	755
R. Schlenk Germany	10	473 0.8×	96 0.2×	183 0.5×	139 1.9×	16 0.3×	20	629
J O Moore United States	9	436 0.7×	102 0.2×	148 0.4×	126 1.7×	36 0.8×	9	600

Countries citing papers authored by Michela Ceccolini

Since Specialization

Citations

This map shows the geographic impact of Michela Ceccolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Ceccolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Ceccolini more than expected).

Fields of papers citing papers by Michela Ceccolini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Ceccolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Ceccolini. The network helps show where Michela Ceccolini may publish in the future.

Co-authorship network of co-authors of Michela Ceccolini

This figure shows the co-authorship network connecting the top 25 collaborators of Michela Ceccolini. A scholar is included among the top collaborators of Michela Ceccolini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michela Ceccolini. Michela Ceccolini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Servili, Chiara, Emanuela Scarpi, Delia Cangini, et al.. (2024). Combining Gene Expression Profiling and Integrated Multidisciplinary Approaches to Improve Prognosis Prediction in Multiple Myeloma. Blood. 144(Supplement 1). 6838–6838.

Marconi, Giovanni, Sonia Ronconi, Delia Cangini, et al.. (2023). Pre-Existing Myeloid Subclones May Account for a Subset of Acute Myeloid Leukemias and Myelodysplastic Neoplasms in Patients with Pre-Existing or Contemporary Lymphoid Disorders. Blood. 142(Supplement 1). 1475–1475.

Catalano, Lucio, et al.. (2022). Addition of carfilzomib as a third agent in lenalidomide-refractory multiple myeloma: Switching from doublet to triplet.. Journal of Clinical Oncology. 40(16_suppl). e20002–e20002. 1 indexed citations

Martino, Massimo, Caterina Alati, Iolanda Donatella Vincelli, et al.. (2021). CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma. Cancers. 13(11). 2639–2639. 23 indexed citations

Rossi, R, Emanuela Scarpi, Monia Dall’Agata, et al.. (2021). Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes. Supportive Care in Cancer. 30(3). 2293–2298. 5 indexed citations

Musuraca, Gerardo, Serena De Matteis, Roberta Napolitano, et al.. (2015). IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia. Journal of Translational Medicine. 13(1). 23 indexed citations

Petrucci, Maria Teresa, Elisabetta Calabrese, Anna Levi, et al.. (2014). Cost of illness in patients with multiple myeloma in Italy: the CoMiM study.. PubMed. 99(4). e193–202. 13 indexed citations

Petrucci, Maria Teresa, Elisabetta Calabrese, Anna Levi, et al.. (2013). Cost of Illness in Patients with Multiple Myeloma in Italy: The CoMiM Study. Tumori Journal. 99(4). e193–e202. 14 indexed citations

Tosi, Patrizia, Elena Zamagni, Paola Tacchetti, et al.. (2010). Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency. Biology of Blood and Marrow Transplantation. 16(8). 1115–1121. 26 indexed citations

10.

Cavo, Michèle, Elena Zamagni, Paola Tacchetti, et al.. (2009). Single or Double Autologous Stem Cell Transplantation Before and After the Era of Novel Agents. Clinical Lymphoma & Myeloma. 9. S51–S52.

11.

Cavo, Michèle, Francesco Di Raimondo, Elena Zamagni, et al.. (2009). Short-Term Thalidomide Incorporated Into Double Autologous Stem-Cell Transplantation Improves Outcomes in Comparison With Double Autotransplantation for Multiple Myeloma. Journal of Clinical Oncology. 27(30). 5001–5007. 34 indexed citations

12.

Tosi, Patrizia, Elena Zamagni, Paola Tacchetti, et al.. (2008). Bortezomib-Thalidomide-Dexamethasone as Primary Induction Therapy for Newly Diagnosed Multiple Myeloma Significantly Decreases Bone Resorption While Sparing Bone Formation as Compared to Thalidomide-Dexamethasone. Blood. 112(11). 5117–5117. 1 indexed citations

13.

Tosi, Patrizia, Carolina Terragna, Nicoletta Testoni, et al.. (2007). Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation. European Journal Of Haematology. 80(1). 31–36. 3 indexed citations

14.

Zamagni, Elena, Cristina Nanni, Francesca Patriarca, et al.. (2007). A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica. 92(1). 50–55. 249 indexed citations

15.

Cavo, Michèle, Giulia Perrone, Michela Ceccolini, et al.. (2007). Superiority of Double over Single Autologous Stem-Cell Transplantation for Newly Diagnosed Multiple Myeloma and Prognostic Impact of Complete Response: Final Analysis of “Bologna 96” Study.. Blood. 110(11). 730–730. 1 indexed citations

16.

Tosi, Patrizia, Elena Zamagni, Claudia Cellini, et al.. (2006). First‐line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma. European Journal Of Haematology. 76(5). 399–404. 42 indexed citations

17.

Cavo, Michèle, Nicoletta Testoni, Carolina Terragna, et al.. (2006). Up-Front Thalidomide-Dexamethasone (THAL) and Double Autologous Transplantation (Double TX) for Multiple Myeloma: Comparison with Double TX without Added Thalidomide and Prognostic Implications of Chromosome 13 Deletion and Translocation t(4;14).. Blood. 108(11). 3081–3081. 11 indexed citations

18.

Terragna, Carolina, Matteo Renzulli, Daniel Remondini, et al.. (2006). Gene Expression Profiling (GEP) of Myeloma (MM) Cells To Predict Attainment (near) Complete Response to Primary Therapy with Thalidomide-Dexamethasone (Thali-Dex) for Newly Diagnosed MM.. Blood. 108(11). 245–245. 4 indexed citations

19.

Cavo, Michèle, Elena Zamagni, Patrizia Tosi, et al.. (2005). Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. Blood. 106(1). 35–39. 258 indexed citations

20.

Tosi, Patrizia, Elena Zamagni, Delia Cangini, et al.. (2005). Bisphosphonates and Osteonecrosis of the Jaws: Incidence in a Homogeneous Series of Patients with Newly Diagnosed Multiple Myeloma Treated with Zoledronic Acid.. Blood. 106(11). 3461–3461. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact